FDA Inspection 1264356 — Moderna US Inc.
The FDA completed an inspection of Moderna US Inc. on Mar 11, 2025 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 11, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Cambridge, MA (United States)
Additional details
Sponsor, Contract Research Organization